Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
national top stories
roche
clinical trials
fda
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
biopharma
blueprint medicines
boehringer ingelheim
cstone pharmaceuticals
dicerna pharamceuticals
duchenne
eli lilly
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
genentech
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
jeff albers
licensing
m&a
medullary thyroid cancer
muscular dystrophy
non-small cell lung cancer
patisiran
pralsetinib
What
roche
3
×
approval
drug
fda
gene
medicines
team
betting
billion
biopharma
blueprint
cancer
candidate
caught
causing
currently
deal
dicerna
disease
duchenne
eye
hepatitis
historic
intended
marketing
medicine
muscle
pact
pay
pharma
pharmaceuticals
producing
protein
puts
recently
regulatory
research
ret
review
rna
Language
unset
3
×
Current search:
deals
×
unset
×
roche
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug